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Metabolic engineering of functional phytochemicals
Abstract
Phytochemicals belonging to the group’s phenols, terpenes, betalains, organosulfides, indoles 
and protein inhibitors are important components in fruits, vegetables, legumes, whole grains and 
nuts that have health promoting benefits and a variety of applications in food and pharmaceutical 
industries. Initially only a few of these important phytochemicals are produced commercially by 
chemical synthesis. However, recent developments in the field of biotechnology have provided 
metabolic engineering strategies that use microorganisms as cell factories for high production 
of these products. This review will discuss the general biosynthetic pathways, metabolic 
engineering and optimization strategies of functional phytochemicals that have received a lot 
of attention from investigators.
Introduction
Phytochemicals are important components in 
fruits, vegetables, legumes, whole grains and nuts 
that have been shown to play a key role in health 
maintenance and onset of diseases. The vast arrays of 
phytochemicals are grouped into phenols, terpenes, 
betalains, organosulfides, indoles and protein 
inhibitors. However, among these major groups, the 
flavonoids and carotenes have been of special interest 
partly due to their health promoting benefits and 
applications in food and pharmaceutical industries 
(Pekkarinen et al., 1999; Valcic et al., 1999 ; Shahidi 
and Ho, 2000; Bradamante et al., 2004; Choi et al., 
2008). 
Initially only a few of these important 
phytochemicals were produced commercially by 
chemical synthesis. However, recent developments 
in the field of biotechnology have provided metabolic 
engineering strategies that use microorganisms as 
cell factories for high production of phytochemicals 
(Lee and Schmidt-Dannert, 2002; Deavours and 
Dixon, 2005; Yan et al., 2005; Leonard et al., 2007; 
Chemler and Koffas, 2008). These developments 
have contributed immensely to independence from 
agriculture and environmental conditions that 
may result to shortages (Krings and Berger, 1998). 
Moreover, the chemical synthesis of these compounds 
is associated with production of racemic mixtures 
and unfriendly environmental conditions coupled 
with high cost of precursors (Barghini et al., 2007). 
Most importantly also is the consumer demand for 
naturally healthy products (Walton et al., 2003).
Metabolic engineering leads to the establishment 
of new metabolic pathways and suppressing or 
removal of existing pathways to enhance the formation 
of a desired product by recombinant DNA techniques. 
This review will discuss the general biosynthetic 
pathways, metabolic engineering and optimization 
strategies of functional phytochemicals that have 
received a lot of attention from investigators.
Phenolics
Polyphenols are found in fruits, vegetables, 
cereals, legumes and beverages. They are generally 
characterised by the presence of hydroxyl groups 
with one or more phenol ring, which in addition 
to other structural elements are used as a basis for 
their classification. They comprise the flavonoids 
(quercetin, kaempferol, catechins), phenolic acids 
(ellagic acids), hydroxycinnamic acids (caffeic acid), 
tryrosol esters (tyrosol), stilbenoids (resveratrol) 
and punicalagins (pomegranates). The importance 
of these compounds lies in their ability to affect 
molecular targets in chronic diseases. They have 
been found to inhibit cyclo-oxygenases (Moroney et 
al., 1988), telomerase and lipoxygenase (Yamamoto 
et al., 1984), induce cell cycle regulation and platelet 
functions (Demrow et al., 1995). Recent studies have 
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proven the anti-diabetic properties via the modulation 
of insulin secretion by pancreatic B cells (Chemler et 
al., 2007).
Flavonoids
Flavonoids are synthesized from phenylalanine 
or tyrosine in the phenylpropanoid pathway via the an 
ordered series of reactions catalysed by phenylalanine 
ammonia lyase (PAL), cinnamate – 4 – hydroxylase 
(C4H), 4 – coumarate:coenzyme A ligase (4CL), 
chalcone synthase (CHS) and chalcone isomerase 
(CHI) to produce flavonoids in plants (Limem et al., 
2008) (Figure 1).
A lot of success has been achieved in the 
biosynthesis of flavonoids by inserting plant 
biosynthetic pathways in recombinant strains of E. 
coli. Sequel to the discovery of 4CL in Streptomyces 
coelicolor capable of activating cinnamic acid 
to cinnamoyl-CoA, engineering techniques have 
been successful in the heterologous production of 
plant specific flavones. A plasmid constructed with 
ribosome binding sequence placed in front of each of 
the three genes (PAL, 4CL and CHS) and transcribed 
by a single promoter placed in front of PAL produced 
high yield of flavanones (Hwang et al., 2003).
A major breakthrough in the biosynthesis of 
flavonoids followed the work of (Leonard et al., 
2006) which devised a strategy for the functional 
expression of plant P450 flavonoid hydroxylase 
in Escherichia coli. Hydroxylated flavonoids 
were produced from p-coumaric acid precursor by 
expressing 4CL together with CHS, CHI, flavanone 
3ß- hydroxylase (FHT) and flavonol synthase 
(FLS). Production levels were later elevated with 
the use of suitable medium rather than high copy 
number of plasmids (Chemler et al., 2007) and by 
increasing precursor metabolites (maloyl-CoA) that 
resulted in the amplification of acetate assimilation 
pathways coupled with overexpression of acetyl-
CoA carboxylase (ACC) (Leonard et al., 2007). 
Other researchers  employed the use of compatible 
vectors, medium pH adjustments, mimicking enzyme 
complex that exist in plants (Yan et al., 2008).
Recently, Leonard et al. (2008) successfully 
produced strains that were capable of high flavonoid 
production. The study engineered an alternative 
carbon assimilation pathway coupled with the 
inhibition of competitive reaction pathways that 
resulted in an increased availability of precursors for 
flavanone and anthocyanin synthesis.
Phenolic acids
Vanillin
Among the phenolic acids, vanillin has attracted 
a lot of interest because of its use as flavour in food 
and cosmetic industries. Vanillin (4-hydroxy-3-
methoxybenzaldehyde) is found in vanilla orchids. The 
unravelling of genes responsible for bioconversion of 
ferulic acid to vanillin in Pseudomonas sp strain HR199 
paved the way for the biosynthesis of vanillin. These 
genes fcs (feruloyl co-enzyme A) and ech (enoyl-coA 
hydratase) were cloned and expressed in E. coli to 
confirm their function. Results of the study indicated 
that the recombinant strains were able to transform 
ferulic acid to vanillin (Figure 2) (Overhage et al., 
1999). Although this study successfully demonstrated 
the biotransformation of ferulic acid to vanillin in an 
economically feasible process, it relies solely on the 
use of expensive substrate ferulic acid. 
Further studies to establish eugenol transformation 
to ferulic acid were exploited by (Overhage et al., 
2003) in a two-step biotransformation strategy. 
Recombinant E. coli strains (carrying vaoA, calA and 
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Figure 1. Biosynthetic routes of plant specific flavonoids: Enzyme names 
are abbreviated as follows: cinnamate-4-hydroxylase (C4H), chalcone 
isomerase (CHI), chalcone synthase (CHS), 4-coumaroyl:CoA-ligase 
(4CL), dihydroflavonol 4-reductase (DFR), flavanone 3-hydroxylase 
(FHT), flavonols synthase (FLS), flavonoid 30-hydroxylase (F30H) or 
flavonoid 30,50-hydroxylase (F3050H), Phe ammonia-lyase (PAL), 
tyrosine ammonia lyase (TAL) (adapted from Limem et al.(2008)
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Figure 2. Metabolic pathway for the production of vanillin in Pseudomonas 
strains (adapted from Walton et al. (2000)
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calB encoding vanillyl alcohol oxidase, coniferyl 
alcohol dehydrogenase and coniferyl aldehyde 
dehydrogenase respectively) were used to produce 
ferulic acid from eugenol and subsequently, E. coli 
(carrying fcs and ech encoding feruloyl coenzymeA 
and enoyl coA hydratase respectively) was used to 
convert the ferulic acid to vanillin.
Genes encoding feruloyl-CoA synthetase and 
feruloyl hydratase in Pseudomonas fluorescence 
have recently been expressed in E. coli. Interestingly, 
production yield of vanillin was increased using low 
copy plasmid of cells from actively growing cultures, 
bioconversion at 30oC and reuse of biomass (Barghini 
et al., 2007).
Curcumin
Curcuminoids produced specifically by plants of 
the order Zingiberales, have been widely used in Asia 
as food additives because of their aromatic, stimulant 
and colouring properties and as traditional medicines 
for a variety of illness (Katsuyama et al., 2008). 
The efficient production of curcuminoid in E. 
coli has been attributed to the use of curcuminoid 
synthase (CUS) – a type III polyketide synthases 
(PKSs) and exogenous supplementation with 
corresponding precursors. Katsuyama et al., (2008) 
efficiently produced curcuminoids in recombinant 
E. coli constructed with an artificial biosynthetic 
pathway comprising PAL (from Rhodotorula rubra), 
4CL (from Lithospernum erythrorhizon) and CUS 
(from Oryza sativa) in tyrosine and/or phenylalanine 
medium (Figure 3).  Improved yields were achieved 
upon removal of PAL in a different system that 
increased the p-coumaroyl-CoA concentration 
but supplementing with phenylpropanoid acids 
(p-coumaric acid, cinnamic acid and ferulic acid).
Stilbenoids
Resveratrol (3,5,4-transhydroxystilbene) is 
present in grapes. Studies have demonstrated the 
health benefits of this compound to be a good 
anti-carcinogenic (Signorelli and Ghidoni, 2005). 
Resveratrol biosynthesis begins with the deamination 
of phenylalanine by phenylalanine ammonia lyase 
(PAL) to produce cinnamic acid, which is then 
hydroxylated by cinnamate-4-hydroxylase (C4H) 
to form 4-coumaric acid. This product is attached 
to CoA by 4-coumarate-CoA ligase (4CL). Next, 
stilbene synthase (STS) condenses 4-coumaroyl-
CoA with three molecules of malonyl-CoA to form 
resveratrol. In heterologous expression systems, 
tyrosine ammonia lyase (TAL) can replace PAL and 
C4H by producing 4-coumaric acid from tyrosine 
(Figure 4) (Kyndt et al., 2002). 
The metabolic engineering approach employed 
in the production of resveratrol accompanied the 
exogenous supplementation of recombinant strains 
with precursors. Studies by (Watts et al., 2006) have 
grafted and expressed the genes responsible for the 
biosynthesis of stilbenes from two different plants 
viz Arabidopsis thaliana (4-coumaroyl CoA ligase 
4CL) and Arachis hypogaea (stilbene synthase STS) 
in E. coli.  The recombinant strains were grown 
in the presence of increasing concentrations of 
phenylpropionic acid precursor (4-coumaric acid) 
to produce stilbene resveratrol and piceatannol. A 
similar strategy has been carried out in Saccharomyces 
cerevisiae paving the way for exploiting yeast in the 
production of resveratrol (Beekwilder et al., 2006).
A different metabolic engineering approach 
employed in the production of resveratrol was 
demonstrated using un-natural fusion proteins that 
offer strategies for improving pathway yields by 
co-localization of enzymes. A construct encoding 
a translational fusion protein of 4CL and STS 
(4CL:STS) was generated and transformed into S. 
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cerevisiae. Expression of 4CL:STS fusion protein in 
the presence of 4-coumaric acid produced increasing 
yields of resveratrol for up to 20 hours (Zhang et al., 
2006).  
Terpenes (Isoprenoids)
Among the terpenes, attention has been focused 
more on the carotenoids (β-Carotene, Lycopene etc) 
which are natural pigments found mostly in vegetables 
and fruits like in carrots, pumpkins, maize, tangerine, 
orange, grapefruit watermelon etc). Investigators 
have reported a number of functions of β-Carotene 
which are independent of their antioxidant role 
(Toma et al., 1995; Santos et al., 1996; Hughes et 
al., 1997). They have also been shown to function as 
chain breaking antioxidants protecting cells and other 
body components from free radical attack (Rock et 
al., 1996). Apart from their potential health benefits, 
they are used industrially as animal feed additives and 
colourants in food and cosmetics (Das et al., 2007). 
Carotenoids are tetraterpenes derived from 5- 
carbon units of isopentenyl diphosphate (IPP) and 
its isomer dimethylallyl diphosphate (DMAPP). Two 
biosynthetic pathways viz G3P (glyceraldehydes 
3- phosphate/pyruvate) and MVA (mevalonic acid) 
have been identified for terpenes, both of which 
lead to the synthesis of IPP (Figures 5 and 6). This 
is followed by isomerization of IPP to dimethylallyl 
pyrophosphate (DMAPP) in the presence of 
isopentenyl pyrophosphate isomerase (idi). These 
two species condense in the presence of geranyl 
pyrophosphate (GPP) and geranyl pyrophosphate 
synthase. Longer chain lengths are formed by further 
iteration of this process (Barkovich and Liao, 2001).
The genes responsible for the biosynthesis of 
carotenoids have been characterised in Erwinia 
species (epiphytic bacteria) and Agrobacterium 
aurantiacum (marine bacterium) (Table 1). A lot 
of studies have been published on the metabolic 
engineering of carotenoids in non – carotenogenic 
bacteria (E. coli and Zymomonas mobilis) and yeast 
(Candida utilis and S. cerevisiae) by redirecting 
carbon flux for the biosynthesis of isoprenoid 
compounds in addition to insertion of crt genes and 
introduction of corresponding microbial crt genes 
under the control of yeast derived promoters and 
terminators respectively (Misawa and Shimada, 
1998). Other investigators increased the supply of 
IPP and DMAPP precursors via the expression of 
key enzymes in MEP and MVA pathways (Wang and 
Keasling, 2002; Yuan et al., 2006). A comparative 
account of the strategies involved in production 
of lycopene in transformed E. coli revealed that 
induction of MVA levels via lycopene incorporation 
of exogenous MVA operons increases the production 
of lycopene than overexpression of deoxyylose 5- 
phosphate synthase (DXS) (Yoon et al., 2007).
Another metabolic engineering approach apart 
from the classical recombinant DNA technology of 
transforming E. coli cells with gene clusters encoding 
carotenoid biosynthetic enzymes is the ordered gene 
assembly in Bacillus subtilis (OGAB). A method for 
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Table 1. Characteristics of the respective Crt enzymes derived from 
Erwinia species and the marine bacteria Agrobacterium aurantiacum and 
Alcaligenes sp. strain PC-1 
Genotype Source Enzyme common names Substrates Products Requirement
s
CrtE Erwinia GGPP synthase FPP GGPP GPP GGPP
CrtB Erwinia, A. aurantiacum Phytoene synthase GGPP Phytoene
CrtI Erwinia, A. aurantiacum Phytoene desaturase Phytoene
z-carotene
Neurosporene
Lycopene Lycopene 
Lycopene
FAD
CrtY Erwinia, A. aurantiacum Lycopene cyclase Lycopene
�-carotene
β -carotene
β -carotene
NADH2
CrtX Erwinia Zeaxanthin glucosyl-
transferase
Zeaxanthin Zeaxanthin-b-D- diglucosid UDP-Glucose
CrtZ Erwinia, A. aurantiacum,
Alcaligenes PC-1
β-carotene hydroxylase β-carotene
Β-cryptoxanthin
Canthaxanthin
Zeaxanthin
Zeaxanthin
Astaxanthin
O2,Fe2+, 2-
oxolase
glutarate
CrtW A. aurantiacum, Alcaligenes PC-1 b-carotene ketolase
(β-carotene oxygenase)
β-carotene Echinenone
Zeaxanthin
Canthaxanthin 
Canthaxanthin
Adonixanthin, (astaxanthin)
O2,Fe2+, 2-
oxolase
glutarate
(adapted from Misawa and Shimada, 1998)
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the assembly of multiple genes with a designated order 
on B. subtilis – E. coli shuttling vectors allows one – 
step assembly of multiple DNA. Using this method, 
rearrangement of crt genes from Pantoea ananatis 
was done in newly designed operons. Transformed 
E. coli strains successfully produced zeaxanthin 
which is comparable to the classical recombinant 
DNA techniques (Nishizaki et al., 2007).
Optimization of carotenoids has been done using 
a variety of strategies. Studies by Kim et al. (2006) 
demonstrated the construction of inducible operons 
that was scaled up gradually to accommodate 
β-carotene production. Findings of the study showed 
the efficient production of β-carotene on low copy 
based vectors which were consistent with previously 
published data (Jones et al., 2000). Several interesting 
results of gene function, recurrence and divergent 
phenotypes obtained from combinatorial gene 
knockout targets for the improvement of recombinant 
strains demonstrated that many diverse genotypes 
can yield same overall phenotypes, pointing to the 
high degree of complexity in metabolic landscapes 
(Alper and Stephanopoulos, 2008).
Conclusions
The understanding of biosynthetic pathways 
leading to the production of phytochemicals in plants 
has been the major success to engineering their 
production in recombinant bacterial and yeast strains. 
Strategies developed through the insertion of plant 
genes of biosynthetic pathways have been successful 
in the production of desired phytochemicals from 
natural, cheap and environmentally friendly sources. 
Different optimization methods have also been 
successful in attaining production scale at industrial 
levels.
Although a lot of progress has been made in 
the metabolic engineering of phytochemicals, 
attention needs to be focused on other functional 
phytochemicals like indoles and protein inhibitors 
which also have wide applications in food and 
pharmaceutical industries. Other microorganisms 
with metabolic engineering potentials should also be 
explored.
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